Gucy2c antibodies to treat cancer
CL202600323A1Pending Publication Date: 2026-07-24JANSSEN BIOTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600323
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-06
- Filing Date
- 2026-02-03
- Publication Date
- 2026-07-24
Abstract
This document describes antibodies or antigen-binding fragments that bind to guanylate cyclase C (GUCY2C), multispecific antibodies comprising them, and methods for treating cancer using them.
Need to check novelty before this filing date? Find Prior Art